S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.49 (+0.72%)
AAPL   116.45 (+1.22%)
MSFT   213.43 (+1.59%)
FB   283.21 (+2.20%)
GOOGL   1,599.47 (+0.96%)
AMZN   3,292.01 (+2.65%)
TSLA   423.80 (+0.84%)
NVDA   535.27 (+1.83%)
BABA   317.36 (+3.42%)
CGC   18.58 (+0.27%)
GE   7.12 (-3.52%)
MU   51.96 (-0.35%)
AMD   79.57 (-3.23%)
T   26.91 (-1.72%)
F   7.91 (-1.49%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.10 (-0.03%)
NIO   28.45 (+9.38%)
BA   155.00 (-3.62%)
DIS   123.31 (-0.60%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.49 (+0.72%)
AAPL   116.45 (+1.22%)
MSFT   213.43 (+1.59%)
FB   283.21 (+2.20%)
GOOGL   1,599.47 (+0.96%)
AMZN   3,292.01 (+2.65%)
TSLA   423.80 (+0.84%)
NVDA   535.27 (+1.83%)
BABA   317.36 (+3.42%)
CGC   18.58 (+0.27%)
GE   7.12 (-3.52%)
MU   51.96 (-0.35%)
AMD   79.57 (-3.23%)
T   26.91 (-1.72%)
F   7.91 (-1.49%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.10 (-0.03%)
NIO   28.45 (+9.38%)
BA   155.00 (-3.62%)
DIS   123.31 (-0.60%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.49 (+0.72%)
AAPL   116.45 (+1.22%)
MSFT   213.43 (+1.59%)
FB   283.21 (+2.20%)
GOOGL   1,599.47 (+0.96%)
AMZN   3,292.01 (+2.65%)
TSLA   423.80 (+0.84%)
NVDA   535.27 (+1.83%)
BABA   317.36 (+3.42%)
CGC   18.58 (+0.27%)
GE   7.12 (-3.52%)
MU   51.96 (-0.35%)
AMD   79.57 (-3.23%)
T   26.91 (-1.72%)
F   7.91 (-1.49%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.10 (-0.03%)
NIO   28.45 (+9.38%)
BA   155.00 (-3.62%)
DIS   123.31 (-0.60%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.49 (+0.72%)
AAPL   116.45 (+1.22%)
MSFT   213.43 (+1.59%)
FB   283.21 (+2.20%)
GOOGL   1,599.47 (+0.96%)
AMZN   3,292.01 (+2.65%)
TSLA   423.80 (+0.84%)
NVDA   535.27 (+1.83%)
BABA   317.36 (+3.42%)
CGC   18.58 (+0.27%)
GE   7.12 (-3.52%)
MU   51.96 (-0.35%)
AMD   79.57 (-3.23%)
T   26.91 (-1.72%)
F   7.91 (-1.49%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.10 (-0.03%)
NIO   28.45 (+9.38%)
BA   155.00 (-3.62%)
DIS   123.31 (-0.60%)
Log in
NASDAQ:BIB

ProShares Ultra Nasdaq Biotechnology Stock Forecast, Price & News

$70.08
+0.71 (+1.02 %)
(As of 10/27/2020 03:59 PM ET)
Add
Today's Range
$69.56
Now: $70.08▼
$70.43
50-Day Range
$61.77
MA: $70.21▼
$79.22
52-Week Range
$35.49
Now: $70.08▼
$83.06
Volume4,704 shs
Average Volume210,097 shs
Market Capitalization$196.22 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.
Read More

Geographic Exposure of BIB

Currency Exposure of BIB

Sector Exposure of BIB

Industry Exposure of BIB

Basic Details

Issuer ProShares
Fund NameProShares Ultra Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BIB
Inception Date4/6/2010
Fund ManagerMichael Neches, Tarak Dave
Webwww.proshares.com
Phone+1-240-4976400

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Biotech Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$193.76 million
Average Daily Volume$162,193.00
Discount/Premium-0.09%

ETF Expenses

Management Fee0.75%
Other Expenses0.29%
Total Expenses1.04%
Fee Waiver-0.09%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial
$70.08
+0.71 (+1.02 %)
(As of 10/27/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BIB News and Ratings via Email

Sign-up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Frequently Asked Questions

How has ProShares Ultra Nasdaq Biotechnology's stock price been impacted by Coronavirus (COVID-19)?

ProShares Ultra Nasdaq Biotechnology's stock was trading at $47.23 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BIB stock has increased by 48.4% and is now trading at $70.08.
View which stocks have been most impacted by COVID-19.

What other stocks do shareholders of ProShares Ultra Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Nasdaq Biotechnology investors own include The Walt Disney (DIS), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), Starbucks (SBUX), Advanced Micro Devices (amd), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Visa (V).

What is ProShares Ultra Nasdaq Biotechnology's stock symbol?

ProShares Ultra Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIB."

Who are ProShares Ultra Nasdaq Biotechnology's major shareholders?

ProShares Ultra Nasdaq Biotechnology's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Toth Financial Advisory Corp (0.74%).

Which institutional investors are selling ProShares Ultra Nasdaq Biotechnology stock?

BIB stock was sold by a variety of institutional investors in the last quarter, including Toth Financial Advisory Corp.

How do I buy shares of ProShares Ultra Nasdaq Biotechnology?

Shares of BIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

One share of BIB stock can currently be purchased for approximately $70.08.

How big of a company is ProShares Ultra Nasdaq Biotechnology?

ProShares Ultra Nasdaq Biotechnology has a market capitalization of $196.22 million.

What is ProShares Ultra Nasdaq Biotechnology's official website?

The official website for ProShares Ultra Nasdaq Biotechnology is www.proshares.com.

How can I contact ProShares Ultra Nasdaq Biotechnology?

ProShares Ultra Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, BETHESDA, MD 20814, United States. The exchange traded fund can be reached via phone at +1-240-4976400.

This page was last updated on 10/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.